Maharashtra hospitals fleece patients
A SIX-MONTH-LONG investigation conducted by Maharashtra's Food and Drug Administration (FDA) has revealed that life-saving coronary stents are sold to patients at exorbitant rates. Also, hospitals do not allow patients to choose from differently priced stents available in the market. FDA's investigation has shown that imported stents costing ` 40,000 are sold to patients at ` 1.25 lakh. Stents of another company costing ` 25,000 are being sold at ` 1.5 lakh. The huge profit is shared among importers, distributors, hospitals and in some cases, doctors. Nearly 350,000 stents are sold every year in Maharashtra alone. If the average price of one stent is ` 1.25 lakh, then it is an industry of over ` 400 crore.